Grace Therapeutics, Inc.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $17.0M | $22.1M | $23.0M | $27.9M | $30.3M | $50.9M | $14.2M | $16.9M |
| Accounts Receivable | — | — | $722.0K | $802.0K | $548.0K | $530.0K | $546.0K | $1.2M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $17.4M | $22.7M | $24.0M | $29.3M | $45.3M | $62.4M | $18.5M | $28.0M |
| Property, Plant & Equipment | $8.0K | $15.0K | $24.0K | $104.0K | $20.9M | — | $1.9M | $2.1M |
| Goodwill | $8.1M | $8.1M | $8.1M | $8.1M | $13.0M | — | — | — |
| Intangible Assets (Excl. Goodwill) | $41.1M | $41.1M | $41.1M | $41.1M | $69.8M | — | $4.2M | $6.4M |
| Total Assets | $66.7M | $72.0M | $73.3M | $79.1M | $128.6M | $62.5M | $22.9M | $36.9M |
| Liabilities | ||||||||
| Accounts Payable | $702.0K | $601.0K | $1.0M | $1.2M | $1.7M | $115.0K | $1.7M | $3.0M |
| Total Current Liabilities | $2.1M | $1.9M | $1.7M | $3.4M | $3.3M | $1.6M | $7.4M | $13.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $2.8M | $5.4M | $11.6M | $11.2M | $20.4M | $6.8M | $9.9M | $25.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-228.5M | $-220.7M | $-211.1M | $-198.3M | $-155.8M | $-146.0M | $-126.3M | $-100.8M |
| Total Stockholders' Equity | $63.9M | $66.6M | $61.7M | $68.0M | $108.3M | $55.7M | $13.0M | $11.0M |